Pune (Maharashtra) [India], February 4 (ANI/PRNewswire): Recently Enzene Biosciences Ltd. announced that it has obtained Marketing Authorisation (MA) from Drug Controller General of India (DCGI) for Teriparatide - bioactive part of human parathyroid hormone (PTH), an anabolic approach to the
New Delhi [India], January 30 (ANI): Pharma giant Serum Institute of India (SII), whose Covishield vaccine has already received restricted emergency use approval by the Drugs Controller General of India (DCGI), has now sought permission to start clinical trials of 'COVOVAX', a COVID-19 vacci
Bengaluru (Karnataka) [India], January 19 (ANI): After the Karnataka Association of Resident Doctors' objected to taking the Covaxin shot developed by Hyderabad-based Bharat Biotech and requested the government to use Covishield vaccine instead, Karnataka Health Minister Dr K Sudhakar on Tue
Hyderabad (Telangana) [India], January 12 (ANI): Dr Reddy's Laboratories has said that independent Data and Safety Monitoring Board (DSMB) reviewed the safety data from phase two clinical trial of Russia's Covid-19 vaccine Sputnik V and recommended phase three recruitment along with continui
New Delhi [India], January 8 (ANI): The Bharat Biotech International Limited has sent a proposal to the Drugs Controller General of India (DCGI) for conducting the phase 1 trials of a nasal vaccine against COVID-19, informed a government official on Friday.
New Delhi [India], January 5 (ANI): Days after Drugs Controller General of India (DCGI) gave approval to two COVID-19 vaccines, Union Health Secretary Rajesh Bhushan on Tuesday said that India is prepared to roll out vaccine within 10 days of emergency use authorisation (EUA), subject to
New Delhi [India], January 5 (ANI): With Drugs Controller General of India (DCGI) approving two vaccine candidates in India, the Kazakhstan Ambassador to India Yerlan Alimbayev said that Kazakhstan will discuss the matter with India and is ready to procure the vaccines.
New Delhi [India], January 4 (ANI): A day after Union Civil Aviation Minister Hardeep Singh Puri called Shashi Tharoor a cynic for criticising the Drugs Controller General of India's (DCGI) approval of COVAXIN for "restricted use in an emergency situation" without this COVID-19 vaccine havin
New Delhi [India], January 4 (ANI): In its permission to Serum Institute of India for "manufacture for sale or distribution" of COVID-19 vaccine 'Covishield', the DGCI has said that the second dose should be administered between four to six weeks after the first dose and also noted that the
New Delhi [India], January 4 (ANI): A day after the Drugs Controller General of India (DCGI) gave its nod for the emergency use approval for two indigenous vaccines against COVID-19 on Sunday, Vice President M Venkaiah Naidu on Monday termed it as India's leap of science and manifestation
Mumbai (Maharashtra) [India], January 4 (ANI): Equity benchmark indices continued their upward march during early hours on Monday after the Drug Controller General of India approved Covid vaccines produced by AstraZeneca and Bharat Biotech for emergency use in the country.
New Delhi [India], January 4 (ANI): The drug regulatory body Drugs Controller General of India (DCGI) has approved Ahmedabad based drug firm Zydus Cadila to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.